MedTrace Logo

Launching a Salt Substitute to Reduce Blood Pressure at the Population Level in Peru

NCT01960972 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2376

Last updated 2021-08-26

No results posted yet for this study

Summary

This protocol aims to implement, using a stepped wedge trial design, a population-level intervention to replace high-sodium salt for a salt substitute (low-sodium, high-potassium salt) to reduce blood pressure levels among adults aged 18 years and over of the semi-urban area of Tumbes.

We hypothesize that participants aged 18 years and over from villages receiving a salt substitute will have lower blood pressure compared to control villages.

Conditions

Interventions

OTHER

Salt substitute

A salt substitute using 25% of potassium chloride and 75% of sodium chloride will be implemented in each of the villages.

Sponsors & Collaborators

Principal Investigators

  • Jaime Miranda, MD, PhD · Universidad Peruana Cayetano Heredia

  • Robert H Gilman, MD · Johns Hopkins Bloomberg School of Public Health

  • Antonio Bernabe-Ortiz, MD, MPH · Universidad Peruana Cayetano Heredia

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2017-03-31
Completion
2017-04-30

Countries

  • Peru

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01960972 on ClinicalTrials.gov